Clinical trial
Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)
NCT00324558 · Clinica Universidad de Navarra, Universidad de Navarra, Other · Terminated
Key facts
| NCT number | NCT00324558 |
|---|---|
| Title | Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) |
| Official title | Multicenter, Randomized, Open and Sequential Study to Evaluate the Efficacy and Safety of Bemiparin Administration on the Response to Treatment in Patients Diagnosed With Limited Small Cell Lung Cancer |
| Lead sponsor | Clinica Universidad de Navarra, Universidad de Navarra, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Small Cell |
| Intervention type | Drug |
| Interventions | Bemiparin |
| Enrollment | 39 |
| Start date | Jun 1, 2005 |
| Primary completion | Feb 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | May 11, 2006 |
| Last update posted | Jun 8, 2012 |
| Countries | Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: